Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 9:15 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 289–312 of 6,287 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Physical Activity Control Clear all

Conditions: Social Media Addiction, Anxiety, Depression Disorder, Wellbeing
Interventions: Mindfulness, Social Media Reduction, Exercise; Behavioral
Lead sponsor: Johns Hopkins Bloomberg School of Public Health; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Aging
Interventions: STEM; Behavioral
Lead sponsor: Kessler Foundation; Other
Eligibility: 60 Years and older
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: East Hanover, New Jersey

Conditions: Asthma
Interventions: ASMAS, Asthma education plus child health; Behavioral
Lead sponsor: Rhode Island Hospital; Other
Eligibility: 11 Years to 14 Years
Enrollment: 243 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Lung Transplantation, Chronic Lung Disease, Muscle Weakness, Rehabilitation
Interventions: IMT- Intervention group, IMT- Placebo group; Device
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Critical Illness
Interventions: ASSIST, Attention-Control; Behavioral
Lead sponsor: Case Western Reserve University; Other
Eligibility: 18 Years and older
Enrollment: 19 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Obesity, Energy Balance, Appetite, Metabolism, Insulin Sensitivity
Interventions: Aerobic exercise, Newsletter; Behavioral
Lead sponsor: Children's Mercy Hospital Kansas City; Other
Eligibility: 14 Years to 17 Years
Enrollment: 31 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Kansas City, Missouri

Conditions: HIV-1 Infection
Interventions: DOR/ISL, BIC/FTC/TAF, Placebo to DOR/ISL, Placebo to BIC/FTC/TAF; Drug
Lead sponsor: Merck Sharp & Dohme LLC; Industry
Eligibility: 18 Years and older
Enrollment: 537 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2029
U.S. locations: 38
States / cities: Phoenix, Arizona • Beverly Hills, California • Los Angeles, California + 29 more

Conditions: Cerebrovascular Disorders, Hemiplegia
Interventions: Robot-Low, Robot-High, Control; Other
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 21 Years and older
Enrollment: 71 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2008
U.S. locations: 4
States / cities: Palo Alto, California • West Los Angeles, California • Houston, Texas + 1 more

Conditions: Heart Failure With Preserved Ejection Fraction, Heart Failure With Reduced Ejection Fraction, Cardiovascular Diseases
Interventions: HBCR; Other
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Breast Cancer, Prostate Cancer, Lung Cancer, Colon Cancer, Melanoma of Skin, Endometrial Cancer, Liver Cancer, Pancreatic Cancer, Rectal Cancer, Kidney Cancer, Other Solid Malignant Tumors
Interventions: Metformin, Coach Directed Behavioral Weight Loss, Self-control weight loss; Drug · Behavioral
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Other
Eligibility: 18 Years and older
Enrollment: 121 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Cancer, Breast, Cancer, Uterus, Cancer, Ovary, Obesity, Activity, Motor, Diet, Healthy
Interventions: With Love, Grandma ("Con Cariño, Abuelita"); Behavioral
Lead sponsor: University of Miami Sylvester Comprehensive Cancer Center; Other
Eligibility: 21 Years and older · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Sarcopenia
Interventions: Peanut protein powder, Full body resistance training; Dietary Supplement · Behavioral
Lead sponsor: Auburn University; Other
Eligibility: 18 Years to 30 Years
Enrollment: 56 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Auburn, Alabama

Conditions: Healthy Volunteers
Interventions: LY2484595, Placebo, Moxifloxacin; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 72 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012
U.S. locations: 2
States / cities: Daytona Beach, Florida • Evansville, Indiana

Conditions: Chronic Neuropathic Pain, Radiculopathy, Sciatica, Peripheral Neuropathic Pain
Interventions: Hypersound RF-PNS system, Sham Hypersound; Device
Lead sponsor: Hypersound Medical Inc; Industry
Eligibility: 18 Years and older
Enrollment: 71 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Healthy, Exercise-Induced Lactic Acidemia
Interventions: Treadmill Exercise, Cooling Gloves, Microbiome Capsule; Other · Device
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Stanford, California

Conditions: Pulmonary Disease, Chronic Obstructive
Interventions: Respimat inhaler, tiotropium+olodaterol (low dose), tiotropium + olodaterol (high dose), placebo to tiotropium+olodaterol; Device · Drug
Lead sponsor: Boehringer Ingelheim; Industry
Eligibility: 40 Years to 75 Years
Enrollment: 404 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 15
States / cities: Torrance, California • Hartford, Connecticut • Springfield, Illinois + 12 more

Conditions: Cryptogenic Symptomatic Transient Ischemic Attack, Cryptogenic Ischemic Stroke
Interventions: Reveal® XT Insertable Cardiac Monitor; Device
Lead sponsor: Medtronic Cardiac Rhythm and Heart Failure; Industry
Eligibility: 40 Years and older
Enrollment: 447 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 19
States / cities: Mountain View, California • Denver, Colorado • Chicago, Illinois + 15 more

Conditions: Major Depressive Disorder
Interventions: Siemens 7T MRI, Sham Neurofeedback; Device
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years to 65 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: New York, New York

Conditions: Pre-diabetes
Interventions: Peer-Led Lifestyle Education on Weight Loss; Behavioral
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older
Enrollment: 402 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: New York, New York

Conditions: Neovascular Age-related Macular Degeneration, nAMD
Interventions: ABP 938 8 mg, Aflibercept (US) 8 mg; Drug
Lead sponsor: Amgen; Industry
Eligibility: 50 Years and older
Enrollment: 304 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 55
States / cities: Fullerton, California • Long Beach, California • Modesto, California + 50 more

Conditions: Spinal Muscular Atrophy Type 3, Mitochondrial Myopathy
Interventions: Not listed
Lead sponsor: Columbia University; Other
Eligibility: 8 Years to 55 Years
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Dementia, Cognitive Dysfunction
Interventions: Preventing Loss of Independence through Exercise (PLIE); Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 288 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Obesity
Interventions: CP-945,598 Treatment B, CP-945,598 Treatment A, Placebo; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 70 Years
Enrollment: 1,253 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 15
States / cities: Peoria, Arizona • Newport Beach, California • Miami, Florida + 12 more

Conditions: Mobility Impairments
Interventions: Virtual Reality (VR), Control; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years to 75 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Birmingham, Alabama

Search by objective public record fields.

Change in Social Media Use and Well-being Among College Students Receiving a Two-week Exercise or Mindfulness Intervention

Theory-Driven Manualized Approach to Improving New Learning and Memory in Healthy Aging and MCI

Peer-Administered Asthma Self-Management Intervention in Urban Middle Schools

Inspiratory Muscle Training Immediately After Lung Transplantation

Self-Management Behaviors of Caregivers of the Chronically Critically Ill

Activity, Adiposity, and Appetite in Adolescents 2 Intervention

DOR/ISL in HIV-1 Antiretroviral Treatment-naïve Participants (MK-8591A-053)

Assisted Movement Neuro-rehabilitation: VA Multi-site Clinical Trial

Home-Based Cardiac Rehabilitation for Patients With Heart Failure

Survivorship Promotion In Reducing IGF-1 Trial

With Love, Grandma ("Con Cariño, Abuelita") Pilot Study

Peanut Protein Supplementation to Augment Muscle Growth and Improve Markers of Muscle Quality and Health in Young Adults

A Study of LY2484595 on the Electrical Activity of the Heart

Hypersound Treatment for Chronic Neuropathic and Radicular Pain

Microbiome Sampling During Endurance Exercise

A Study to Determine the Effect of Tiotropium + Olodaterol Fixed Dose Combination on Exercise Endurance Time During Constant Work Rate Cycle Ergometry Test in COPD

Study of Continuous Cardiac Monitoring to Assess Atrial Fibrillation After Cryptogenic Stroke

Network Neurofeedback Using 7-Tesla MRI to Reduce Rumination Levels in Depression

Effectiveness Study of Community-Based, Peer-Led Education on Weight Loss and Diabetes

A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration

Oxidative Capacity and Exercise Tolerance in Ambulatory SMA

Preventing Loss of Independence Through Exercise in Community Living Centers

Effect of 2-year Administration of CP-945,598 on Weight Loss Efficacy and Safety.

The Effects of Virtual Reality Greenspace on Stress Among Adults With Mobility Impairments